logo
Tony Robbins' No. 1 Solution to Saving Money for Retirement

Tony Robbins' No. 1 Solution to Saving Money for Retirement

Yahoo18 hours ago
When it comes to saving for retirement, bestselling personal finance author and motivational speaker, Tony Robbins, said most Americans are saving nowhere near enough — instead, relying on Social Security to carry them through their golden years.
Yet, given the average monthly Social Security paycheck is only $2,002.39 (per Kiplinger), Americans are asking for trouble. $2,000 dollars a month doesn't even cover the rent on a one-bedroom apartment in many places.
Trending Now:
Learn More:
Robbins claimed people fail to save for retirement because they psychologically view saving money for some unknowable time in the future as a sacrifice in the present they are unable to make. Simply put, the future does not feel real. In the mind of most Americans, who can plan for the phantom future when medical debt and student loans need to be paid off?
In his book, 'MONEY Master the Game: 7 Simple Steps to Financial Freedom,' Robbins wrote, 'the bottom line is, if we feel like we're losing something, we avoid it; we won't do it. That's why so many people don't save and invest. Saving sounds like you're giving something up, you're losing something today. But you're not. It's giving yourself a gift today of peace of mind, of certainty or the large fortune in your future.'
In the wake of recent retirement warnings, Robbins proposed a solution to saving money for retirement.
This is why, according to The Street, Robbins advocates for the 'Save More Tomorrow' plan, originally the brainchild of economists Richard Thaler and Shlomo Benartzi.
In this model, employees are not asked to make any major cuts to their current spending. Instead, they start out saving negligible amounts of their income — even just 3% — and then increase the percentage at some point in the future ('tomorrow') when their income increases. They repeat this process of saving larger and larger percentages each and every time they get a pay raise until, before they know it, they have accrued substantial retirement savings.
According to Thaler and Benartzi, people don't feel this type of saving as a loss because they can't miss what they never had.
Check Out:
Thaler and Benartzi tested the 'Save More Tomorrow' plan on employees at a company in the Midwest who stated they could not afford to save any of their paycheck.
'After just five years, those employees who thought they couldn't afford to save were setting aside just under a whopping 14% of their paychecks,' stated Robbins. 'And 65% of them were actually saving an average of 19% of their salaries.'
Saving for retirement can feel like a large, overwhelming task that can cause pain in the present — a pain which most seek to avoid. But, by simply reframing the task and transferring the bulk of the 'pain' to a later date (when income increases), participants became willing to pull the trigger… and didn't feel that pain.
The 'Save More Tomorrow' plan can serve as an excellent psychological hack if you're prone to procrastinating. It actively tricks you into planning and saving for retirement which will help you establish a more secure financial future.
Additionally, you'll wind up benefitting from compound interest earned over time on retirement accounts like 401(k)s and IRAs. As the saying goes, 'wealth is money and time.' And a few dollars saved today could means thousands of dollars secured down the line.
More From GOBankingRates
3 Luxury SUVs That Will Have Massive Price Drops in Summer 2025
Mark Cuban Tells Americans To Stock Up on Consumables as Trump's Tariffs Hit -- Here's What To Buy
These Cars May Seem Expensive, but They Rarely Need Repairs
This article originally appeared on GOBankingRates.com: Tony Robbins' No. 1 Solution to Saving Money for Retirement
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

BrightSpring's Onco360 Becomes National Pharmacy Partner for New Cancer, Rare Disease Therapies
BrightSpring's Onco360 Becomes National Pharmacy Partner for New Cancer, Rare Disease Therapies

Yahoo

time35 minutes ago

  • Yahoo

BrightSpring's Onco360 Becomes National Pharmacy Partner for New Cancer, Rare Disease Therapies

BrightSpring Health Services Inc. (NASDAQ:BTSG) is one of the best new stocks to buy now. On June 18, BrightSpring Health Services announced that its specialty pharmacy, called Onco360, has been chosen as the national pharmacy partner for several newly approved therapies. These innovative treatments target advanced cancers and rare genetic disorders. BrightSpring delivers care and clinical solutions to 400,000+ customers, clients, and patients daily across all 50 states. Onco360 will provide access, education, data, and expert support for patients suffering from advanced ovarian and lung cancers, as well as neurofibromatosis type 1. A medical technician using surgical robotics to perform minimally-invasive urologic surgery in an operating room. Onco360 has been selected as a pharmacy partner for the following specific medication therapies: GOMEKLI, which is approved for adult and pediatric patients aged 2 years and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas/PN not suitable for complete resection; AVMAPKI FAKZYNJA CO-PACK, which is approved for adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer/LGSOC who have received prior systemic therapy; and IBTROZI, which is approved for adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC). BrightSpring Health Services Inc. (NASDAQ:BTSG) is a home and community-based healthcare services platform in the US that operates through 2 segments: Pharmacy Solutions and Provider Services. Onco360 is a national, independent Oncology Pharmacy and clinical support services company. While we acknowledge the potential of BTSG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Waystar Study Highlights AI's Critical Role, Proven ROI in Healthcare Payments
Waystar Study Highlights AI's Critical Role, Proven ROI in Healthcare Payments

Yahoo

time35 minutes ago

  • Yahoo

Waystar Study Highlights AI's Critical Role, Proven ROI in Healthcare Payments

Waystar Holding Corp. (NASDAQ:WAY) is one of the best new stocks to buy now. On June 23, Waystar announced the findings of a commissioned study conducted by Forrester Consulting. The study is titled 'AI in Healthcare Payments Software: A Strategic Imperative,' and revealed that AI is becoming increasingly critical in revenue cycle management/RCM due to its proven impact and measurable ROI. The research shows acceleration in AI adoption within healthcare. 82% of healthcare leaders now consider AI an integral part of their RCM operations, with 70% identifying it as a top organizational priority. The study also found that AI is delivering improvements in key revenue cycle metrics, such as a 13% to 37% improvement in high-impact areas such as claim accuracy, denial prevention, workforce efficiency, and payment speed. A medical professional with a patient explaining the effects of neurostimulation treatments. Trust in AI is growing, with 60% of decision-makers reporting increased confidence since implementing AI. ~ 70% of healthcare leaders view AI as a high or critical organizational priority, and 60% plan to increase their AI investment. The study is based on responses from 300+ healthcare leaders and highlights a preference for existing RCM software partners when it comes to AI capabilities. Waystar serves ~30,000 clients and represents over 1 million distinct providers, including 16 of the top 20 institutions on the US News Best Hospitals list. Waystar Holding Corp. (NASDAQ:WAY) develops a cloud-based software solution for healthcare payments. While we acknowledge the potential of WAY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Solventum Amends Thermo Fisher Deal, Retains Water Filtration Business
Solventum Amends Thermo Fisher Deal, Retains Water Filtration Business

Yahoo

time35 minutes ago

  • Yahoo

Solventum Amends Thermo Fisher Deal, Retains Water Filtration Business

Solventum Corporation (NYSE:SOLV) is one of the best new stocks to buy now. On June 25, Solventum announced an amendment to its transaction agreement with Thermo Fisher Scientific Inc. (NYSE:TMO). The revised agreement now excludes Solventum's drinking water filtration business from the assets being acquired by Thermo Fisher. Consequently, the cash consideration for the acquisition has been adjusted from ~$4.1 billion to $4 billion. The net proceeds from this sale are intended for debt reduction. This amendment is expected to streamline the transaction and accelerate its closure, which is still expected by the end of this year. Under the new terms, Thermo Fisher will be entitled to a payment of up to $75 million from Solventum. Keeping the Water Business is projected to increase Solventum's annual EPS gain by $0.15 to $0.2. A healthcare professional wearing a health communications device discussing patient data with a colleague. The terms of the amended agreement remain largely consistent with the initial agreement, with modifications specifically reflecting the exclusion of the Water Business. These adjustments include changes to non-compete clauses and related provisions, as well as certain reverse services, manufacturing, and supply agreements that will now support the retained Water Business. Solventum Corporation (NYSE:SOLV) is a healthcare company that develops, manufactures, and commercializes a portfolio of solutions to address customer and patient needs internationally. Thermo Fisher Scientific Inc. (NYSE:TMO) provides life sciences solutions, analytical instruments, specialty diagnostics, laboratory products, and biopharma services internationally. While we acknowledge the potential of SOLV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store